Found: 28
Select item for more details and to access through your institution.
Increased serum insulin associated with increased risk of prostate cancer recurrence.
- Published in:
- Prostate, 2002, v. 50, n. 1, p. 1, doi. 10.1002/pros.10026
- By:
- Publication type:
- Article
Gleason 7 prostate cancer treated with low-dose-rate brachytherapy: lack of impact of primary Gleason pattern on biochemical failure.
- Published in:
- BJU International, 2012, v. 110, n. 9, p. 1257, doi. 10.1111/j.1464-410X.2012.11057.x
- By:
- Publication type:
- Article
Long-term potency preservation following brachytherapy for prostate cancer.
- Published in:
- BJU International, 2012, v. 110, n. 2, p. 221, doi. 10.1111/j.1464-410X.2011.10800.x
- By:
- Publication type:
- Article
Outcomes for patients with high-grade prostate cancer treated with a combination of brachytherapy, external beam radiotherapy and hormonal therapy.
- Published in:
- BJU International, 2009, v. 104, n. 11, p. 1631, doi. 10.1111/j.1464-410X.2009.08661.x
- By:
- Publication type:
- Article
Effect of low dose-rate prostate brachytherapy on the sexual health of men with optimal sexual function before treatment: analysis at ≥ 7 years of follow-up.
- Published in:
- BJU International, 2007, v. 100, n. 2, p. 362, doi. 10.1111/j.1464-410X.2007.07016.x
- By:
- Publication type:
- Article
Urinary symptom flare after brachytherapy for prostate cancer is associated with erectile dysfunction and more urinary symptoms before implantation.
- Published in:
- BJU International, 2006, v. 98, n. 5, p. 979, doi. 10.1111/j.1464-410X.2006.06398.x
- By:
- Publication type:
- Article
Serum thyroid-stimulating hormone is elevated in men with Gleason 8 prostate cancer.
- Published in:
- BJU International, 2005, v. 96, n. 3, p. 328, doi. 10.1111/j.1464-410X.2005.05625.x
- By:
- Publication type:
- Article
C-reactive protein is significantly associated with prostate-specific antigen and metastatic disease in prostate cancer.
- Published in:
- BJU International, 2005, v. 95, n. 7, p. 961, doi. 10.1111/j.1464-410X.2005.05447.x
- By:
- Publication type:
- Article
Phase II Trial of Concurrent Sunitinib and Image-Guided Radiotherapy for Oligometastases.
- Published in:
- PLoS ONE, 2012, v. 7, n. 6, p. e36979, doi. 10.1371/journal.pone.0036979
- By:
- Publication type:
- Article
Re: Insulin-Like Growth Factor-I (IGF-1) and IGF Binding Protein-3 as Predictors of Advanced-Stage Prostate Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2002, v. 94, n. 24, p. 1893
- By:
- Publication type:
- Article
Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
- Published in:
- Cancer (0008543X), 1996, v. 77, n. 11, p. 2386, doi. 10.1002/(SICI)1097-0142(19960601)77:11<2386::AID-CNCR30>3.0.CO;2-R
- By:
- Publication type:
- Article
Ocular complications with the use of radium-223: a case series.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The effect of disease and treatment-related factors on biopsy results after prostate brachytherapy: implications for treatment optimization.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Screening breast cancer patients for ATM mutations and polymorphisms by using denaturing high-performance liquid chromatography.
- Published in:
- Environmental & Molecular Mutagenesis, 2001, v. 38, n. 2/3, p. 200, doi. 10.1002/em.1072
- By:
- Publication type:
- Article
Stage T3b prostate cancer diagnosed by seminal vesicle biopsy and treated with neoadjuvant hormone therapy, permanent brachytherapy and external beam radiotherapy.
- Published in:
- BJU International, 2019, v. 123, n. 2, p. 277, doi. 10.1111/bju.14464
- By:
- Publication type:
- Article
Factors influencing long‐term urinary symptoms after prostate brachytherapy.
- Published in:
- BJU International, 2018, v. 122, n. 5, p. 831, doi. 10.1111/bju.14365
- By:
- Publication type:
- Article
Outcomes and toxicities in patients with intermediate-risk prostate cancer treated with brachytherapy alone or brachytherapy and supplemental external beam radiation therapy.
- Published in:
- BJU International, 2018, v. 121, n. 5, p. 774, doi. 10.1111/bju.14128
- By:
- Publication type:
- Article
Low-dose-rate brachytherapy for prostate cancer: outcomes at >10 years of follow-up.
- Published in:
- BJU International, 2018, v. 121, n. 5, p. 781, doi. 10.1111/bju.14122
- By:
- Publication type:
- Article
The relative importance of hormonal therapy and biological effective dose in optimizing prostate brachytherapy treatment outcomes.
- Published in:
- BJU International, 2013, v. 112, n. 2, p. E44, doi. 10.1111/bju.12166
- By:
- Publication type:
- Article
Haematuria after prostate brachytherapy.
- Published in:
- BJU International, 2013, v. 111, n. 8, p. E319, doi. 10.1111/j.1464-410X.2012.11697.x
- By:
- Publication type:
- Article
Temporal patterns of selected late toxicities in patients treated with brachytherapy or brachytherapy plus external beam radiation for prostate adenocarcinoma.
- Published in:
- BJU International, 2013, v. 111, n. 3b, p. E43, doi. 10.1111/j.1464-410X.2012.11436.x
- By:
- Publication type:
- Article
Biopsy Results after Real-Time Ultrasound-Guided Transperineal Implants for Stage T<sub>1</sub>-T<sub>2</sub> Prostate Cancer.
- Published in:
- Journal of Endourology, 2000, v. 14, n. 4, p. 375, doi. 10.1089/end.2000.14.375
- By:
- Publication type:
- Article
Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features.
- Published in:
- JAMA Network Open, 2021, v. 4, n. 6, p. e2115312, doi. 10.1001/jamanetworkopen.2021.15312
- By:
- Publication type:
- Article
Oligoprogression of Solid Tumors on Immune Checkpoint Inhibitors: The Impact of Local Ablative Radiation Therapy.
- Published in:
- Biomedicines, 2022, v. 10, n. 10, p. N.PAG, doi. 10.3390/biomedicines10102481
- By:
- Publication type:
- Article
Erratum: Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases.
- Published in:
- 2011
- By:
- Publication type:
- Erratum
Phase 1 Study of Concurrent Sunitinib and Image-Guided Radiotherapy Followed by Maintenance Sunitinib for Patients With Oligometastases.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 15, p. 3571, doi. 10.1002/cncr.24412
- By:
- Publication type:
- Article
Phase 1 study of concurrent sunitinib and image-guided radiotherapy followed by maintenance sunitinib for patients with oligometastases: acute toxicity and preliminary response.
- Published in:
- 2009
- By:
- Publication type:
- journal article